NXTM Financial Facts

Net loss per share, basic and diluted: -0.09
Net loss before income taxes: -4.8M
See Full Income Statement

Accrued expenses: 21.03M
Total liabilities and stockholders' equity: -622.29M
See Full Balance Sheet

Nxstage Medical, Inc. (NXTM) Earnings

  |   Expand Research on NXTM
Next EPS Date N/A EPS Growth Rate -12.5% *Last Qtr.
Average EPS % Beat Rate +7.3% Revenue Growth Rate +17.2% *Last Qtr.
Average % Move 1-Wk after EPS +3.2% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/8/14 Q114 -$0.09-$0.11 +$0.02$72.2M$69.44M N/A Details
2/27/14 Q413 -$0.08-$0.09 +$0.01$69.4M$67.66M N/A Details
11/7/13 Q313 -$0.08-$0.07 -$0.01$66.9M$66.77M = Details
7/25/13 Q213 -$0.06-$0.07 +$0.01$65.5M$64.66M = Details
2/28/13 Q412 $0.00-$0.05 +$0.05N/A$63.54M = Details
5/2/13 Q113 -$0.08-$0.08 $0.00$61.6M$61.14M = Details
11/8/12 Q312 -$0.04-$0.06 +$0.02$61.2M$60.81M = Details
8/8/12 Q212 -$0.09-$0.10 +$0.01$59M$58.22M = Details